A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia

Syed S. Hasan, Alexandra M. Clavarino, Abdullah A. Mamun, Therese Kairuz

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

BACKGROUND: Once a disease of developed countries, type 2 diabetes mellitus (T2DM) has become widespread worldwide. For people with T2DM, achievement of therapeutic outcomes demands the rational and quality use of medicine.

AIMS: The primary aim of this study was to examine the prevalence of diabetes and prescribing patterns of anti-diabetic medications in Australia and Malaysia.

METHODS: The most recent, publicly available, statistical reports (2004-2008) on the use of medicines published in Australia and in Malaysia were evaluated. Defined daily doses (DDDs/1,000 population/day) were derived from the reports and used to rank and compare individual drug use.

RESULTS: There was an increasing trend in the prevalence of diabetes in Australia, although there is a greater predicted increase in prevalence for Malaysia. While drugs used for the treatment of diabetes were not the most highly used drugs in Australia, their use increased during the study period, from 42.64 to 48.61 DDD/1,000/day. Anti-diabetic drugs were the most frequently dispensed class of drugs in Malaysia. Although the total consumption of anti-diabetic drugs in Malaysia decreased between 2006 and 2007 (from 40.30 to 39.72), this was followed by a marked increase to 46.69 in 2008. There was a marked reduction in the dispensing of insulin in Malaysia from 2004 to 2007 (7.77 to 3.23).

CONCLUSION: The use of drugs to treat diabetes does not reflect the usage patterns found in Australia. Effective drug use reviews are required to ensure impartial access in middle- and low-income countries.

LanguageEnglish
Pages179-188
Number of pages10
JournalAustralasian Medical Journal
Volume8
Issue number6
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Drug Utilization
Malaysia
Pharmaceutical Preparations
Dichlorodiphenyldichloroethane
Type 2 Diabetes Mellitus
Drug Utilization Review
Developed Countries
Medicine
Insulin

Cite this

Hasan, Syed S. ; Clavarino, Alexandra M. ; Mamun, Abdullah A. ; Kairuz, Therese. / A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia. In: Australasian Medical Journal. 2015 ; Vol. 8, No. 6. pp. 179-188.
@article{3052cb86aeeb47fcb8ac1913e7b33031,
title = "A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia",
abstract = "BACKGROUND: Once a disease of developed countries, type 2 diabetes mellitus (T2DM) has become widespread worldwide. For people with T2DM, achievement of therapeutic outcomes demands the rational and quality use of medicine.AIMS: The primary aim of this study was to examine the prevalence of diabetes and prescribing patterns of anti-diabetic medications in Australia and Malaysia.METHODS: The most recent, publicly available, statistical reports (2004-2008) on the use of medicines published in Australia and in Malaysia were evaluated. Defined daily doses (DDDs/1,000 population/day) were derived from the reports and used to rank and compare individual drug use.RESULTS: There was an increasing trend in the prevalence of diabetes in Australia, although there is a greater predicted increase in prevalence for Malaysia. While drugs used for the treatment of diabetes were not the most highly used drugs in Australia, their use increased during the study period, from 42.64 to 48.61 DDD/1,000/day. Anti-diabetic drugs were the most frequently dispensed class of drugs in Malaysia. Although the total consumption of anti-diabetic drugs in Malaysia decreased between 2006 and 2007 (from 40.30 to 39.72), this was followed by a marked increase to 46.69 in 2008. There was a marked reduction in the dispensing of insulin in Malaysia from 2004 to 2007 (7.77 to 3.23).CONCLUSION: The use of drugs to treat diabetes does not reflect the usage patterns found in Australia. Effective drug use reviews are required to ensure impartial access in middle- and low-income countries.",
keywords = "Australia, Diabetes, Drugs, Insulin, Malaysia, Metformin, Utilisation",
author = "Hasan, {Syed S.} and Clavarino, {Alexandra M.} and Mamun, {Abdullah A.} and Therese Kairuz",
year = "2015",
doi = "10.21767/AMJ.2015.2330",
language = "English",
volume = "8",
pages = "179--188",
journal = "Australasian Medical Journal",
issn = "1836-1935",
publisher = "The Australasian Medical Journal Pty. Ltd.",
number = "6",

}

A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia. / Hasan, Syed S.; Clavarino, Alexandra M.; Mamun, Abdullah A.; Kairuz, Therese.

In: Australasian Medical Journal, Vol. 8, No. 6, 2015, p. 179-188.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia

AU - Hasan, Syed S.

AU - Clavarino, Alexandra M.

AU - Mamun, Abdullah A.

AU - Kairuz, Therese

PY - 2015

Y1 - 2015

N2 - BACKGROUND: Once a disease of developed countries, type 2 diabetes mellitus (T2DM) has become widespread worldwide. For people with T2DM, achievement of therapeutic outcomes demands the rational and quality use of medicine.AIMS: The primary aim of this study was to examine the prevalence of diabetes and prescribing patterns of anti-diabetic medications in Australia and Malaysia.METHODS: The most recent, publicly available, statistical reports (2004-2008) on the use of medicines published in Australia and in Malaysia were evaluated. Defined daily doses (DDDs/1,000 population/day) were derived from the reports and used to rank and compare individual drug use.RESULTS: There was an increasing trend in the prevalence of diabetes in Australia, although there is a greater predicted increase in prevalence for Malaysia. While drugs used for the treatment of diabetes were not the most highly used drugs in Australia, their use increased during the study period, from 42.64 to 48.61 DDD/1,000/day. Anti-diabetic drugs were the most frequently dispensed class of drugs in Malaysia. Although the total consumption of anti-diabetic drugs in Malaysia decreased between 2006 and 2007 (from 40.30 to 39.72), this was followed by a marked increase to 46.69 in 2008. There was a marked reduction in the dispensing of insulin in Malaysia from 2004 to 2007 (7.77 to 3.23).CONCLUSION: The use of drugs to treat diabetes does not reflect the usage patterns found in Australia. Effective drug use reviews are required to ensure impartial access in middle- and low-income countries.

AB - BACKGROUND: Once a disease of developed countries, type 2 diabetes mellitus (T2DM) has become widespread worldwide. For people with T2DM, achievement of therapeutic outcomes demands the rational and quality use of medicine.AIMS: The primary aim of this study was to examine the prevalence of diabetes and prescribing patterns of anti-diabetic medications in Australia and Malaysia.METHODS: The most recent, publicly available, statistical reports (2004-2008) on the use of medicines published in Australia and in Malaysia were evaluated. Defined daily doses (DDDs/1,000 population/day) were derived from the reports and used to rank and compare individual drug use.RESULTS: There was an increasing trend in the prevalence of diabetes in Australia, although there is a greater predicted increase in prevalence for Malaysia. While drugs used for the treatment of diabetes were not the most highly used drugs in Australia, their use increased during the study period, from 42.64 to 48.61 DDD/1,000/day. Anti-diabetic drugs were the most frequently dispensed class of drugs in Malaysia. Although the total consumption of anti-diabetic drugs in Malaysia decreased between 2006 and 2007 (from 40.30 to 39.72), this was followed by a marked increase to 46.69 in 2008. There was a marked reduction in the dispensing of insulin in Malaysia from 2004 to 2007 (7.77 to 3.23).CONCLUSION: The use of drugs to treat diabetes does not reflect the usage patterns found in Australia. Effective drug use reviews are required to ensure impartial access in middle- and low-income countries.

KW - Australia

KW - Diabetes

KW - Drugs

KW - Insulin

KW - Malaysia

KW - Metformin

KW - Utilisation

UR - http://www.scopus.com/inward/record.url?scp=84934764249&partnerID=8YFLogxK

U2 - 10.21767/AMJ.2015.2330

DO - 10.21767/AMJ.2015.2330

M3 - Article

VL - 8

SP - 179

EP - 188

JO - Australasian Medical Journal

T2 - Australasian Medical Journal

JF - Australasian Medical Journal

SN - 1836-1935

IS - 6

ER -